Synthetic biology concept stocks strengthen, SHENGDA BIO-PHARM hits the daily limit in the afternoon
On April 10th, synthetic biology concept stocks strengthened. As of 14:23, SHENGDA BIO-PHARM hit the daily limit, Sanyuan Biotechnology, BLB, SC Pharmaceuticals, and Kingdomway had previously hit the daily limit, while Jinbo Biology and Wuxi Jinghai rose over 10%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments